EXPRESSION OF THE BILE ACID-INDUCIBLE NADH-FLAVIN OXIDOREDUCTASE GENE OF EUBACTERIUM SP VPI-12708 IN ESCHERICHIA-COLI

被引:8
作者
BARON, SF [1 ]
HYLEMON, PB [1 ]
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1995年 / 1249卷 / 02期
关键词
BILE ACID-INDUCIBLE; NADH; FLAVIN OXIDOREDUCTASE; (EUBACTERIUM);
D O I
10.1016/0167-4838(95)00034-R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The intestinal microorganism Eubacterium sp. VPI 12708 synthesizes a bile acid-inducible NADH:flavin oxidoreductase (NADH:FOR) which presumably functions in the 7 alpha-dehydroxylation of cholic acid to deoxycholic acid. The baiH gene encoding NADH:FOR was subcloned into an IPTG-inducible expression vector, pBaiH2.2. Escherichia coli DH5 alpha cells transformed with pBaiH2.2 expressed 10-fold higher levels of NADH:FOR upon induction with IPTG than did Eubacterium sp. VPI 12708 cells induced with cholic acid. The NADH:FOR produced by E. coli DH5 alpha(pBaiH2.2) was purified to >95% electrophoretic homogeneity in three steps. The purified NADH:FOR was similar to that of Eubacterium sp. VPI 12708 in subunit and native M(r) (ca. 72000 and 210000, respectively), pH optimum, sensitivity to inhibitors, and electron acceptor specificity. It contained 1 mol of FAD, up to 2 mol of iron, and 1 mol of copper per mol of subunit. The enzyme reduced synthetic quinones, dyes, flavins, and O-2 With NADH as the electron donor, but did not reduce disulfide compounds, various unsaturated bile acids, cytochrome c, physiological quinones, or cell fractions from Eubacterium sp. VPI 12708. Addition of purified NADH:FOR to Eubacterium sp. VPI 12708 cell extracts altered the balance of oxidized and reduced bile acid intermediates produced during cholic acid 7 alpha-dehydroxylation, suggesting that the enzyme may regulate the cellular ratio of NAD to NADH.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 38 条
  • [1] Hayakawa, Adv. Lipids Res., 11, pp. 143-192, (1973)
  • [2] Hylemon, Glass, Human Intestinal Microflora in Health and Disease, pp. 189-213, (1983)
  • [3] Sjovall, Clin. Chim. Acta, 5, pp. 33-41, (1960)
  • [4] Carey, Sterols and Bile Acids, pp. 345-403, (1985)
  • [5] Hoffmann, Roda, J. Lipid Res., 25, pp. 1477-1489, (1984)
  • [6] Vlahcevic, Heuman, Hylemon, Hepatology. A Textbook of Liver Disease, pp. 341-377, (1990)
  • [7] White, Lipsky, Fricke, Hylemon, Steroids, 35, pp. 103-109, (1980)
  • [8] White, Cacciapuoti, Fricke, Whitehead, Mosbach, Hylemon, J. Lipid Res., 22, pp. 891-898, (1981)
  • [9] White, Fricke, Hylemon, J. Lipid Res., 23, pp. 145-153, (1982)
  • [10] White, Paone, Cacciapuoti, Fricke, Mosbach, Hylemon, J. Lipid Res., 24, pp. 20-27, (1983)